Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332826 · ClinicalTrials.gov registry record · Phase 3
Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
A Phase 3 study, sponsored by Mannkind Corporation.
- Terminated
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT00332826 is a Phase 3 study that was terminated before completion, run by Mannkind Corporation. The registered enrollment target is 3 participants.
The verdict
NCT00332826, a Phase 3 study, was terminated before completion, sponsored by Mannkind Corporation.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
The clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes mellitus and concurrent asthma.
Interventions
- DRUG Technosphere Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00332826
The ClinicalTrials.gov registry entry for NCT00332826 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mannkind Corporation, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Technosphere Insulin is the first listed.
NCT00332826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00332826 about?
NCT00332826 is a clinical study titled "Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma". The clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes mellitus and concurrent asthma.
What is the current status of trial NCT00332826?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2006-06. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00332826?
The interventions under investigation include: Technosphere Insulin (DRUG).
Who is sponsoring clinical trial NCT00332826?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.